Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2014 | 08-2013 | 08-2012 | 08-2011 | 08-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,312 | -654 | -286 | -230 | -740 |
| Depreciation Amortization | 131 | 6 | 11 | 1 | 10 |
| Accounts receivable | -229 | 4 | N/A | N/A | N/A |
| Other Working Capital | -277 | 322 | 38 | 40 | -50 |
| Other Operating Activity | 1,058 | 217 | 118 | 19 | 560 |
| Operating Cash Flow | $-630 | $-106 | $-119 | $-170 | $-220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | N/A | -2 | 0 | 0 |
| Net Acquisitions | -66 | -71 | N/A | 0 | 0 |
| Investing Cash Flow | $-67 | $-71 | $-2 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,702 | 153 | 65 | N/A | N/A |
| Debt Repayment | -1,036 | -45 | -28 | N/A | N/A |
| Common Stock Issued | 10 | 106 | 75 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 170 | 230 |
| Financing Cash Flow | $675 | $215 | $112 | $170 | $230 |
| Beginning Cash Position | 40 | 2 | 11 | 10 | 1 |
| End Cash Position | 18 | 40 | 2 | 10 | 10 |
| Net Cash Flow | $-22 | $38 | $-9 | $0 | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -630 | -106 | -119 | -170 | -220 |
| Capital Expenditure | -1 | N/A | -2 | N/A | N/A |
| Free Cash Flow | -631 | -106 | -121 | -170 | -220 |